pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-ETH-2021-00301 | Ethiopia | 2,021 | National referral | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Close | Positive | Negative | Equivocal | 14.5 | Negative | null | Resection | Yes | 7 | moderate_burden |
PATH-NIG-2023-00302 | Nigeria | 2,023 | District | Cervix | 8890/3 | Leiomyosarcoma | Well differentiated | Absent | Not documented | Close | Positive | Negative | Positive | Not done | Negative | null | Excisional biopsy | No - inconclusive | 25 | moderate_burden |
PATH-ETH-2019-00303 | Ethiopia | 2,019 | Regional | Stomach | 8720/3 | Melanoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 60.3 | Negative | null | Excisional biopsy | Yes | 14 | moderate_burden |
PATH-NIG-2018-00304 | Nigeria | 2,018 | Regional | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Negative | Negative | 89.8 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-SOU-2025-00305 | South Africa | 2,025 | Regional | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | Not done | Negative | null | Excisional biopsy | No - inconclusive | 16 | moderate_burden |
PATH-KEN-2024-00306 | Kenya | 2,024 | National referral | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 56.4 | Positive | null | Resection | Yes | 27 | moderate_burden |
PATH-NIG-2018-00307 | Nigeria | 2,018 | District | Stomach | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | 35.7 | Positive | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-UGA-2024-00308 | Uganda | 2,024 | Regional | Ovary | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 56.0 | Positive | null | Resection | Yes | 26 | moderate_burden |
PATH-UGA-2019-00309 | Uganda | 2,019 | Regional | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Positive | Positive | 48.0 | Positive | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-SOU-2022-00310 | South Africa | 2,022 | National referral | Ovary | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Negative | Not done | Negative | Negative | 71.6 | Positive | null | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-SOU-2025-00311 | South Africa | 2,025 | National referral | Thyroid | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Not done | 52.0 | Not done | null | Fine needle aspirate | Yes | 26 | moderate_burden |
PATH-GHA-2019-00312 | Ghana | 2,019 | National referral | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Present | Negative | Positive | Negative | Not done | 80.7 | Positive | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-SOU-2020-00313 | South Africa | 2,020 | Regional | Breast | 8500/3 | Ductal carcinoma | Undifferentiated | Present | Present | Not applicable | Negative | Negative | Negative | 48.6 | Not done | Triple negative | Excisional biopsy | Yes | 14 | moderate_burden |
PATH-NIG-2021-00314 | Nigeria | 2,021 | Regional | Liver | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Absent | Absent | Negative | Negative | Not done | Negative | 38.9 | Negative | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-UGA-2025-00315 | Uganda | 2,025 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Close | Negative | Negative | Positive | Not done | Negative | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-ETH-2022-00316 | Ethiopia | 2,022 | National referral | Cervix | 8260/3 | Papillary carcinoma | Moderately differentiated | Present | Absent | Positive | Positive | Not done | Not done | 35.8 | Positive | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-TAN-2020-00317 | Tanzania | 2,020 | National referral | Lung | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Not documented | Not applicable | Positive | Positive | Negative | 38.1 | Positive | null | Resection | Yes | 22 | moderate_burden |
PATH-NIG-2019-00318 | Nigeria | 2,019 | National referral | Bladder | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 46.0 | Negative | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-UGA-2023-00319 | Uganda | 2,023 | Regional | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Positive | Negative | Negative | Negative | 59.8 | Positive | null | Fine needle aspirate | Yes | 11 | moderate_burden |
PATH-TAN-2022-00320 | Tanzania | 2,022 | Regional | Thyroid | 8510/3 | Medullary carcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | 26.4 | Positive | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-GHA-2024-00321 | Ghana | 2,024 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Positive | 30.5 | Negative | null | Resection | Yes | 20 | moderate_burden |
PATH-UGA-2025-00322 | Uganda | 2,025 | National referral | Ovary | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Negative | Negative | 70.2 | Positive | null | Core needle biopsy | No - inconclusive | 13 | moderate_burden |
PATH-UGA-2018-00323 | Uganda | 2,018 | Regional | Liver | 8890/3 | Leiomyosarcoma | Undifferentiated | Not documented | Present | Negative | Negative | Positive | Positive | 86.7 | Positive | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-SOU-2021-00324 | South Africa | 2,021 | National referral | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Close | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-KEN-2018-00325 | Kenya | 2,018 | Regional | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Positive | Positive | Positive | Negative | 84.2 | Negative | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-NIG-2020-00326 | Nigeria | 2,020 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Close | Positive | Positive | Negative | Not done | Positive | null | Fine needle aspirate | Yes | 4 | moderate_burden |
PATH-SOU-2024-00327 | South Africa | 2,024 | District | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-KEN-2023-00328 | Kenya | 2,023 | Regional | Ovary | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Not done | 46.4 | Positive | null | Excisional biopsy | No - inconclusive | 4 | moderate_burden |
PATH-GHA-2022-00329 | Ghana | 2,022 | National referral | Bladder | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 6.4 | Positive | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-NIG-2025-00330 | Nigeria | 2,025 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Negative | Equivocal | 46.3 | Negative | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-UGA-2019-00331 | Uganda | 2,019 | Regional | Breast | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Positive | Negative | 83.7 | Negative | Luminal A | Excisional biopsy | No - inconclusive | 22 | moderate_burden |
PATH-SOU-2018-00332 | South Africa | 2,018 | District | Ovary | 8890/3 | Leiomyosarcoma | Moderately differentiated | Present | Present | Positive | Negative | Negative | Negative | 89.7 | Positive | null | Resection | Yes | 10 | moderate_burden |
PATH-ETH-2022-00333 | Ethiopia | 2,022 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Present | Close | Positive | Positive | Negative | 82.1 | Positive | null | Core needle biopsy | Yes | 26 | moderate_burden |
PATH-SOU-2021-00334 | South Africa | 2,021 | National referral | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Not documented | Positive | Negative | Positive | Negative | 12.0 | Positive | Triple negative | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-ETH-2019-00335 | Ethiopia | 2,019 | National referral | Breast | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 58.7 | Positive | Triple negative | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-GHA-2023-00336 | Ghana | 2,023 | District | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Negative | Negative | Not done | Not done | null | Fine needle aspirate | Yes | 20 | moderate_burden |
PATH-ETH-2018-00337 | Ethiopia | 2,018 | Regional | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Close | Positive | Negative | Negative | 83.4 | Negative | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-SOU-2019-00338 | South Africa | 2,019 | Regional | Stomach | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Not applicable | Positive | Positive | Negative | 55.9 | Not done | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-NIG-2023-00339 | Nigeria | 2,023 | Regional | Prostate | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Not documented | Absent | Negative | Positive | Not done | Negative | Not done | Not done | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-NIG-2024-00340 | Nigeria | 2,024 | Regional | Ovary | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Positive | Not done | 24.7 | Not done | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-NIG-2020-00341 | Nigeria | 2,020 | National referral | Lung | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Negative | Negative | 39.6 | Negative | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-ETH-2022-00342 | Ethiopia | 2,022 | District | Bladder | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Present | Negative | Positive | Not done | Negative | Not done | Positive | null | Resection | No - inconclusive | 19 | moderate_burden |
PATH-KEN-2022-00343 | Kenya | 2,022 | District | Lung | 8500/3 | Ductal carcinoma | Well differentiated | Not documented | Absent | Negative | Positive | Not done | Positive | Not done | Positive | null | Core needle biopsy | No - suboptimal | 17 | moderate_burden |
PATH-GHA-2019-00344 | Ghana | 2,019 | Regional | Bladder | 8510/3 | Medullary carcinoma | Undifferentiated | Not documented | Not documented | Negative | Positive | Negative | Negative | Not done | Positive | null | Resection | No - inconclusive | 24 | moderate_burden |
PATH-SOU-2021-00345 | South Africa | 2,021 | District | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Positive | Positive | Not done | Positive | Not done | Positive | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-TAN-2019-00346 | Tanzania | 2,019 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Not applicable | Negative | Positive | Negative | Not done | Positive | null | Fine needle aspirate | Yes | 27 | moderate_burden |
PATH-ETH-2020-00347 | Ethiopia | 2,020 | Regional | Ovary | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Not done | Positive | Equivocal | 18.2 | Not done | null | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-UGA-2020-00348 | Uganda | 2,020 | District | Ovary | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Not applicable | Negative | Not done | Negative | Not done | Positive | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-NIG-2019-00349 | Nigeria | 2,019 | National referral | Breast | 8720/3 | Melanoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Not done | 21.4 | Negative | Luminal A | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-NIG-2022-00350 | Nigeria | 2,022 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | 72.9 | Positive | null | Excisional biopsy | Yes | 10 | moderate_burden |
PATH-NIG-2023-00351 | Nigeria | 2,023 | District | Liver | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Close | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-ETH-2021-00352 | Ethiopia | 2,021 | District | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Not documented | Negative | Negative | Positive | Negative | 25.8 | Not done | null | Excisional biopsy | No - inconclusive | 20 | moderate_burden |
PATH-KEN-2021-00353 | Kenya | 2,021 | Regional | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Not documented | Close | Negative | Positive | Negative | 43.6 | Positive | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-UGA-2020-00354 | Uganda | 2,020 | Regional | Stomach | 8430/3 | Mucoepidermoid carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | 33.0 | Not done | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-TAN-2022-00355 | Tanzania | 2,022 | District | Cervix | 8510/3 | Medullary carcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-GHA-2021-00356 | Ghana | 2,021 | District | Cervix | 8260/3 | Papillary carcinoma | Well differentiated | Present | Absent | Negative | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | No - inconclusive | 13 | moderate_burden |
PATH-TAN-2024-00357 | Tanzania | 2,024 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Positive | Negative | Positive | Equivocal | 31.1 | Positive | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-TAN-2024-00358 | Tanzania | 2,024 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-KEN-2022-00359 | Kenya | 2,022 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Negative | Positive | Negative | Negative | 17.8 | Negative | null | Excisional biopsy | No - inconclusive | 13 | moderate_burden |
PATH-SOU-2022-00360 | South Africa | 2,022 | Regional | Colorectal | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Present | Close | Negative | Positive | Negative | Not done | Positive | null | Resection | No - inconclusive | 5 | moderate_burden |
PATH-NIG-2025-00361 | Nigeria | 2,025 | District | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | Not done | Positive | null | Fine needle aspirate | Yes | 4 | moderate_burden |
PATH-KEN-2019-00362 | Kenya | 2,019 | Regional | Bladder | 8890/3 | Leiomyosarcoma | Poorly differentiated | Present | Absent | Not applicable | Positive | Not done | Negative | 68.1 | Positive | null | Resection | Yes | 21 | moderate_burden |
PATH-NIG-2025-00363 | Nigeria | 2,025 | Regional | Bladder | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | 71.1 | Positive | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-TAN-2019-00364 | Tanzania | 2,019 | Regional | Liver | 8140/3 | Adenocarcinoma | Well differentiated | Present | Not documented | Positive | Positive | Positive | Positive | 32.0 | Positive | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-ETH-2025-00365 | Ethiopia | 2,025 | Regional | Stomach | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Present | Negative | Negative | Positive | Negative | 60.9 | Negative | null | Resection | Yes | 11 | moderate_burden |
PATH-NIG-2019-00366 | Nigeria | 2,019 | District | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Not applicable | Negative | Positive | Positive | Not done | Negative | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-TAN-2023-00367 | Tanzania | 2,023 | Regional | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 47.7 | Positive | null | Resection | Yes | 24 | moderate_burden |
PATH-ETH-2019-00368 | Ethiopia | 2,019 | District | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Negative | Negative | Not done | Negative | null | Resection | Yes | 20 | moderate_burden |
PATH-UGA-2020-00369 | Uganda | 2,020 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Well differentiated | Not documented | Not documented | Negative | Negative | Positive | Positive | 18.4 | Not done | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-TAN-2018-00370 | Tanzania | 2,018 | District | Lung | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Positive | Positive | 84.3 | Negative | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-KEN-2022-00371 | Kenya | 2,022 | National referral | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Not done | Negative | 84.5 | Positive | HER2+ | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-ETH-2018-00372 | Ethiopia | 2,018 | District | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Not done | Negative | Not done | Positive | null | Excisional biopsy | Yes | 21 | moderate_burden |
PATH-TAN-2024-00373 | Tanzania | 2,024 | District | Liver | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Absent | Close | Positive | Negative | Negative | 25.2 | Positive | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-KEN-2024-00374 | Kenya | 2,024 | District | Lung | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Absent | Close | Negative | Positive | Negative | Not done | Negative | null | Resection | Yes | 22 | moderate_burden |
PATH-TAN-2021-00375 | Tanzania | 2,021 | National referral | Stomach | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Close | Negative | Negative | Negative | 81.2 | Positive | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-NIG-2019-00376 | Nigeria | 2,019 | District | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Positive | Not done | Not done | Not done | null | Excisional biopsy | Yes | 17 | moderate_burden |
PATH-KEN-2021-00377 | Kenya | 2,021 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 21.0 | Positive | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-TAN-2024-00378 | Tanzania | 2,024 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Close | Not done | Not done | Negative | 25.2 | Positive | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-ETH-2019-00379 | Ethiopia | 2,019 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Well differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | 21.1 | Negative | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-KEN-2025-00380 | Kenya | 2,025 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Positive | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-UGA-2024-00381 | Uganda | 2,024 | National referral | Prostate | 8720/3 | Melanoma | Moderately differentiated | Present | Absent | Close | Positive | Positive | Negative | 56.2 | Negative | null | Fine needle aspirate | Yes | 24 | moderate_burden |
PATH-NIG-2025-00382 | Nigeria | 2,025 | National referral | Breast | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Absent | Close | Positive | Negative | Negative | 46.5 | Negative | Triple negative | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-ETH-2025-00383 | Ethiopia | 2,025 | Regional | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Not done | Not done | Negative | 11.0 | Positive | null | Resection | Yes | 13 | moderate_burden |
PATH-UGA-2024-00384 | Uganda | 2,024 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-GHA-2021-00385 | Ghana | 2,021 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Not applicable | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | No - inconclusive | 26 | moderate_burden |
PATH-ETH-2022-00386 | Ethiopia | 2,022 | National referral | Stomach | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 32.2 | Negative | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-UGA-2021-00387 | Uganda | 2,021 | Regional | Prostate | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Positive | Positive | 69.6 | Positive | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-TAN-2018-00388 | Tanzania | 2,018 | District | Ovary | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Positive | Negative | Not done | Negative | null | Resection | No - suboptimal | 22 | moderate_burden |
PATH-SOU-2021-00389 | South Africa | 2,021 | National referral | Liver | 8500/3 | Ductal carcinoma | Undifferentiated | Present | Present | Close | Negative | Negative | Negative | 50.8 | Positive | null | Resection | No - inconclusive | 18 | moderate_burden |
PATH-SOU-2019-00390 | South Africa | 2,019 | District | Prostate | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Equivocal | 34.9 | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-ETH-2023-00391 | Ethiopia | 2,023 | Regional | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Close | Positive | Positive | Negative | Not done | Negative | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-NIG-2019-00392 | Nigeria | 2,019 | Regional | Lung | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Negative | Positive | Negative | Negative | 50.0 | Not done | null | Excisional biopsy | Yes | 20 | moderate_burden |
PATH-GHA-2019-00393 | Ghana | 2,019 | District | Cervix | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Absent | Negative | Not done | Positive | Negative | Not done | Positive | null | Resection | No - inconclusive | 26 | moderate_burden |
PATH-ETH-2018-00394 | Ethiopia | 2,018 | District | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Positive | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-UGA-2018-00395 | Uganda | 2,018 | District | Breast | 8260/3 | Papillary carcinoma | Poorly differentiated | Not documented | Absent | Close | Positive | Negative | Negative | Not done | Negative | Luminal B | Fine needle aspirate | Yes | 23 | moderate_burden |
PATH-UGA-2021-00396 | Uganda | 2,021 | District | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-TAN-2020-00397 | Tanzania | 2,020 | National referral | Cervix | 8310/3 | Clear cell carcinoma | Well differentiated | Present | Absent | Negative | Negative | Positive | Positive | 62.4 | Positive | null | Resection | Yes | 19 | moderate_burden |
PATH-SOU-2020-00398 | South Africa | 2,020 | District | Stomach | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Absent | Positive | Not done | Positive | Negative | Not done | Positive | null | Resection | Yes | 22 | moderate_burden |
PATH-NIG-2025-00399 | Nigeria | 2,025 | District | Thyroid | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Positive | Not done | Positive | null | Resection | No - inconclusive | 13 | moderate_burden |
PATH-TAN-2019-00400 | Tanzania | 2,019 | Regional | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Not applicable | Not done | Positive | Negative | 44.6 | Positive | null | Excisional biopsy | Yes | 18 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.